105 related articles for article (PubMed ID: 11153539)
1. A review of the neuropathology of schizophrenia.
Halliday GM
Clin Exp Pharmacol Physiol; 2001; 28(1-2):64-5. PubMed ID: 11153539
[TBL] [Abstract][Full Text] [Related]
2. The neuropathology of schizophrenia. A critical review of the data and their interpretation.
Harrison PJ
Brain; 1999 Apr; 122 ( Pt 4)():593-624. PubMed ID: 10219775
[TBL] [Abstract][Full Text] [Related]
3. Notes from the graveyard: neuropathology and schizophrenia.
Roberts GW; Bruton CJ
Neuropathol Appl Neurobiol; 1990 Feb; 16(1):3-16. PubMed ID: 2181332
[TBL] [Abstract][Full Text] [Related]
4. Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype.
Turetsky B; Cowell PE; Gur RC; Grossman RI; Shtasel DL; Gur RE
Arch Gen Psychiatry; 1995 Dec; 52(12):1061-70. PubMed ID: 7492258
[TBL] [Abstract][Full Text] [Related]
5. Neuropathology of schizophrenia: a mini review.
Iritani S
Neuropathology; 2007 Dec; 27(6):604-8. PubMed ID: 18021384
[TBL] [Abstract][Full Text] [Related]
6. Frontal and temporal volume size of grey and white matter in patients with schizophrenia: an MRI parcellation study.
Okugawa G; Tamagaki C; Agartz I
Eur Arch Psychiatry Clin Neurosci; 2007 Aug; 257(5):304-7. PubMed ID: 17464546
[TBL] [Abstract][Full Text] [Related]
7. Quantitative shape analysis of the temporal and prefrontal lobes of schizophrenic patients: a magnetic resonance image study.
Casanova MF; Goldberg TE; Suddath RL; Daniel DG; Rawlings R; Lloyd DG; Loats HL; Kleinman JE; Weinberger DR
J Neuropsychiatry Clin Neurosci; 1990; 2(4):363-72. PubMed ID: 2136388
[TBL] [Abstract][Full Text] [Related]
8. Temporal-lobe length is reduced, and gyral folding is increased in schizophrenia: a post-mortem study.
Highley JR; Esiri MM; McDonald B; Cooper SJ; Crow TJ
Schizophr Res; 1998 Nov; 34(1-2):1-12. PubMed ID: 9824872
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics.
Wierzba-Bobrowicz T; Lewandowska E; Lechowicz W; Stepień T; Pasennik E
Folia Neuropathol; 2005; 43(2):81-9. PubMed ID: 16012909
[TBL] [Abstract][Full Text] [Related]
10. [Neuropathology of scizophrenia--from a new perspective].
Iritani S
Brain Nerve; 2007 Jun; 59(6):605-16. PubMed ID: 17585592
[TBL] [Abstract][Full Text] [Related]
11. Asymmetry of the uncinate fasciculus: a post-mortem study of normal subjects and patients with schizophrenia.
Highley JR; Walker MA; Esiri MM; Crow TJ; Harrison PJ
Cereb Cortex; 2002 Nov; 12(11):1218-24. PubMed ID: 12379610
[TBL] [Abstract][Full Text] [Related]
12. [Structural brain changes in patients with schizophrenic psychoses. From focal pathology to network disorder].
Falkai P; Vogeley K; Maier W
Nervenarzt; 2001 May; 72(5):331-41. PubMed ID: 11386143
[TBL] [Abstract][Full Text] [Related]
13. [MRI findings in schizophrenic patient with frontal lobe atrophy].
Kimura N; Inayama Y; Shigenobu K; Kakiuchi Y; Tabushi K
Seishin Shinkeigaku Zasshi; 2004; 106(2):152-60. PubMed ID: 15052786
[TBL] [Abstract][Full Text] [Related]
14. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
15. Is there gliosis in schizophrenia? Investigation of the temporal lobe.
Roberts GW; Colter N; Lofthouse R; Johnstone EC; Crow TJ
Biol Psychiatry; 1987 Dec; 22(12):1459-68. PubMed ID: 3315013
[TBL] [Abstract][Full Text] [Related]
16. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.
Deakin FW; Simpson MD; Slater P; Hellewell JS
J Psychopharmacol; 1997; 11(2):133-42. PubMed ID: 9254279
[TBL] [Abstract][Full Text] [Related]
17. Hemispheric asymmetry of frontal and temporal gray matter and age of onset in schizophrenia.
Maher BA; Manschreck TC; Yurgelun-Todd DA; Tsuang MT
Biol Psychiatry; 1998 Sep; 44(6):413-7. PubMed ID: 9777170
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia.
Virgo L; Humphries C; Mortimer A; Barnes T; Hirsch S; de Belleroche J
Biol Psychiatry; 1995 May; 37(10):694-701. PubMed ID: 7640324
[TBL] [Abstract][Full Text] [Related]
19. Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study.
Meisenzahl EM; Koutsouleris N; Gaser C; Bottlender R; Schmitt GJ; McGuire P; Decker P; Burgermeister B; Born C; Reiser M; Möller HJ
Schizophr Res; 2008 Jul; 102(1-3):150-62. PubMed ID: 18439804
[TBL] [Abstract][Full Text] [Related]
20. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
Ho BC; Andreasen NC; Nopoulos P; Arndt S; Magnotta V; Flaum M
Arch Gen Psychiatry; 2003 Jun; 60(6):585-94. PubMed ID: 12796222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
